Australia markets open in 1 hour 30 minutes

Nova Eye Medical Limited (EYE.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.2750+0.0100 (+3.77%)
At close: 03:51PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 62.92M
Enterprise value 61.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.68
Price/book (mrq)3.70
Enterprise value/revenue 3.28
Enterprise value/EBITDA -7.69

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 30.00%
S&P500 52-week change 323.57%
52-week high 30.3250
52-week low 30.1150
50-day moving average 30.2336
200-day moving average 30.2154

Share statistics

Avg vol (3-month) 3506.04k
Avg vol (10-day) 3355.07k
Shares outstanding 5228.8M
Implied shares outstanding 6228.8M
Float 8159.77M
% held by insiders 116.21%
% held by institutions 122.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 421 July 2020
Last split factor 21:5
Last split date 310 July 2001

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -76.24%
Operating margin (ttm)-55.29%

Management effectiveness

Return on assets (ttm)-23.09%
Return on equity (ttm)-68.36%

Income statement

Revenue (ttm)18.77M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)20.80%
Gross profit (ttm)N/A
EBITDA -7.54M
Net income avi to common (ttm)-14.31M
Diluted EPS (ttm)-0.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.61M
Total cash per share (mrq)0.01
Total debt (mrq)1.22M
Total debt/equity (mrq)7.14%
Current ratio (mrq)1.47
Book value per share (mrq)0.09

Cash flow statement

Operating cash flow (ttm)-6.36M
Levered free cash flow (ttm)-1.25M